13 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... commonly used hypoglycaemic ... agents #Diabetes ... #Diabetic #Medications ... #Pharmacology #
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... for type 2 diabetes ... experience unexplained hypoglycemia ... #Prescribing #Pharmacology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... in Diabetes Management ... AmyChung #Oral #Hypoglycemics ... #Diabetes #Management ... #pharmacology #
Sulfonylureas - Pharmacology Summary
Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... Summary Mechanisms ... cells, triggering insulin ... : Weight gain, Hypoglycemia ... diabetes #endocrinology
Insulin Degludec (Tresiba) vs Insulin Glargine (Lantus, Basaglar, or Toujeo)

Insulin degludec (Tresiba) is an ultra-long acting
Insulin Degludec ... do require BID dosing ... incidence of severe hypoglycemia ... Glargine #Comparison #Pharmacology ... #DEVOTE #Diabetes
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... • Increases insulin-mediated ... Does not cause hypoglycemia ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... -> Stimulates Insulin ... minimal chance of hypoglycemia ... #Pharmacology # ... Management #Diabetes
Vasopressors and Inotropes
 • Norepinephrine - Levophed - "Levo" - Generally thought of as the first
adjunctive) • Phenylephrine ... Vasopressors #Inotropes #management ... #criticalcare # ... summary #comparison ... #table #pharmacology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... medications for insulin ... a low risk of hypoglycemia ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
also present with Hypoglycemia ... drips unless also diabetic ... you risk causing Hypoglycemia ... differential #algorithm #management ... #treatment #criticalcare